These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9258365

  • 1. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues.
    Bryant SD, Guerrini R, Salvadori S, Bianchi C, Tomatis R, Attila M, Lazarus LH.
    J Med Chem; 1997 Aug 01; 40(16):2579-87. PubMed ID: 9258365
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
    Breveglieri A, Guerrini R, Salvadori S, Bianchi C, Bryant SD, Attila M, Lazarus LH.
    J Med Chem; 1996 Feb 02; 39(3):773-80. PubMed ID: 8576920
    [Abstract] [Full Text] [Related]

  • 3. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.
    Bryant SD, Attila M, Salvadori S, Guerrini R, Lazarus LH.
    Pept Res; 1994 Feb 02; 7(4):175-84. PubMed ID: 7696838
    [Abstract] [Full Text] [Related]

  • 4. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ, Wild KD, Misicka A, Lipkowski A, Haaseth RC, Hruby VJ, Weber SJ, Davis TP, Yamamura HI, Porreca F.
    J Pharmacol Exp Ther; 1993 May 02; 265(2):896-902. PubMed ID: 8388462
    [Abstract] [Full Text] [Related]

  • 5. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M, Nakagawa T, Seki T, Onogi T, Aoki Y, Katao Y, Katsumata S, Satoh M.
    Mol Pharmacol; 1996 Nov 02; 50(5):1413-22. PubMed ID: 8913373
    [Abstract] [Full Text] [Related]

  • 6. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, Lazarus LH.
    J Med Chem; 1997 Sep 12; 40(19):3100-8. PubMed ID: 9301674
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov 12; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

  • 10. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
    Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Bryant SD, Jinsmaa Y, Lazarus LH.
    J Med Chem; 2004 Jul 29; 47(16):4066-71. PubMed ID: 15267245
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Folding trends in a flexible peptide: two-dimensional NMR study of deltorphin-I, a delta selective opioid heptapeptide.
    Duchesne D, Naim M, Nicolas P, Baron D.
    Biochem Biophys Res Commun; 1993 Sep 15; 195(2):630-6. PubMed ID: 8373402
    [Abstract] [Full Text] [Related]

  • 13. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y, Zhang X, Homma K, Rice KC, Calderon SN, Rothman RB, Yamamura HI, Davis P, Flippen-Anderson JL, Xu H, Becketts K, Foltz EJ, Porreca F.
    J Med Chem; 1997 Aug 29; 40(18):2936-47. PubMed ID: 9288176
    [Abstract] [Full Text] [Related]

  • 14. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec 29; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 15. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS, Zheng MQ, Murray TF, Aldrich JV.
    J Med Chem; 2003 Sep 11; 46(19):4002-8. PubMed ID: 12954053
    [Abstract] [Full Text] [Related]

  • 16. Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors.
    Salvadori S, Bryant SD, Bianchi C, Balboni G, Scaranari V, Attila M, Lazarus LH.
    J Med Chem; 1993 Nov 26; 36(24):3748-56. PubMed ID: 8254604
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and binding properties of deltorphin I analogues containing (R) and (S)-alpha-hydroxymethylnaphtylalanine.
    Olma A, Gniadzik A, Lipkowski AW, Lachwa M.
    Acta Biochim Pol; 2001 Nov 26; 48(4):1165-8. PubMed ID: 11995986
    [Abstract] [Full Text] [Related]

  • 18. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 19. Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues.
    Marastoni M, Guerrini R, Balboni G, Salvadori S, Fantin G, Fogagnolo M, Lazarus LH, Tomatis R.
    Arzneimittelforschung; 1999 Jan 14; 49(1):6-12. PubMed ID: 10028372
    [Abstract] [Full Text] [Related]

  • 20. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
    Nikiforovich GV, Kolodziej SA, Nock B, Bernad N, Martinez J, Marshall GR.
    Biopolymers; 1995 Oct 14; 36(4):439-52. PubMed ID: 7578939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.